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Abstract 
The past 40 years have seen a dramatic emergence of epidemic arboviral diseases transmitted primarily by mos‑
quitoes. The frequency and magnitude of the epidemics, especially those transmitted by urban Aedes species, have 
progressively increased over time, accelerating in the past 10 years. To reduce the burden and threat of vector‑borne 
diseases, the World Health Organization (WHO) has recently adopted the Global Vector Control Response (GVCR) in 
order to support countries in implementing effective sustainable vector control. The evidence‑base to support vector 
control is however limited for arboviral diseases which make prioritization difficult. Knowledge gaps in the distribu‑
tion, mechanisms and impact of insecticide resistance on vector control impedes the implementation of locally 
tailored Aedes control measures. This report summarizes the main outputs of the second international conference of 
the Worldwide Insecticide resistance Network (WIN) on “Integrated approaches and innovative tools for combating insec-
ticide resistance in arbovirus vectors” held in Singapore, 1–3 October 2018. The aims of the conference were to review 
progress and achievements made in insecticide resistance surveillance worldwide, and to discuss the potential of 
integrated vector management and innovative technologies for efficiently controlling arboviral diseases. The confer‑
ence brought together 150 participants from 26 countries.
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Background
Arboviruses transmitted by Aedes mosquitoes such as 
dengue, Zika, chikungunya, yellow fever, and recently 
Mayaro virus represent an increasing threat to pub-
lic health worldwide [1]. The Global Vector Control 
Response (GVCR) recently adopted by the WHO assem-
bly aims to reduce the burden and threat of vector-borne 
diseases by 2030 through effective, locally-adapted sus-
tainable vector control [2]. The evidence-base to support 
vector control is limited for arboviral diseases (ABVs) 
due to a lack of research support and intervention data, 
especially in areas where mosquitoes are resistant to 
commonly used public health pesticides [3].
A recent systematic review [4] highlights that 57 coun-
tries already reported resistance or suspected resistance 
to at least one chemical class of insecticides in Aedes 
aegypti or Ae. albopictus mosquitoes. Resistance is now 
recognized as a major threat for the control of ABVs and 
has likely contributed to their re-emergence and spread 
in some parts of the world [5]. Important knowledge 
gaps remain on mosquito resistance including its dis-
tribution, dynamics, mechanisms, fitness costs and its 
impact on vector control efficacy [4]. Furthermore, there 
is an urgent need to review progress and achievements 
made in the deployment of integrated approaches and 
innovative technologies for the surveillance and control 
of arbovirus vectors [3] and to discuss their potential for 
mitigating insecticide resistance [6].
In March 2016, TDR, the Special Programme for 
Research and Training in Tropical Diseases, in col-
laboration with the WHO Neglected Tropical Diseases 
Department (NTD/WHO), supported the launch of the 
first-ever international network to track insecticide resist-
ance in mosquito vectors of arboviruses. The Worldwide 
Insecticide Resistance Network (WIN) (http://win-netwo 
rk.ird.fr/), aims to enhance the surveillance of insecticide 
resistance worldwide, filling knowledge gaps and guid-
ing decision making for improved insecticide resistance 
management strategies and vector control [7].
From 1 to 3 October 2018, the WIN organized its 2nd 
International Conference on “Integrated approaches and 
innovative tools for combating insecticide resistance in 
arbovirus vectors”. Held in Singapore, the conference was 
organized jointly by the French Institut de Recherche 
pour le Développement (IRD) and Duke-NUS Medi-
cal School of Singapore and has been recognized as an 
event of the “France-Singapore Year of Innovation 2018”. 
The first WIN international conference, held in Rio de 
Janeiro, Brazil from 5 to 8 December 2016, highlighted 
the need for more partnerships between academia, 
research institutions, international organizations, stake-
holders, the civil society and the private sector to man-
age insecticide resistance and sustain vector control in 
endemic areas and countries facing vector-borne disease 
outbreaks [8]. Consequently, during the 2018 confer-
ence, representatives from 69 institutions working on 
vector-borne diseases were present including research 
institutions and universities, WHO, ministries of health, 
environment, foreign affairs and defense, but also mem-
bers of the private sectors. This multi-sectorial confer-
ence brought together about 150 participants from 26 
nationalities.
During this second conference, three scientific plenary 
sessions were organized: the first session dedicated to 
the “Control of emerging arboviral diseases” addressed 
the public health priorities and responses for reduc-
ing the burden of arboviral diseases. The second session 
was dedicated to “Insecticide resistance” and focused on 
the levels, spatial distribution, mechanisms and impact 
of insecticide resistance on arbovirus control and resist-
ance management options. The last plenary session was 
dedicated to “Innovative vector control approaches” and 
presented community-based and integrated approaches 
for Aedes mosquito control and discussed the latest 
developments (chemical, biological and genetic tools) 
for reducing arbovirus transmission. Each plenary ses-
sion comprised multiple presentations by scientists fol-
lowed by open discussions with all participants. Scientific 
sessions were followed by a plenary “Public-private ini-
tiatives in public health”, where representatives of the 
agrochemical sector, research institutions, vector control 
consortium and international organizations presented 
initiatives for fostering innovation in public health. In 
addition, 25 posters were presented by scientists and 
industry. Finally, two round tables open to all participants 
were organized to leverage the knowledge of the audi-
ence into strategies that may accelerate the translation of 
vector research into policies and programmes. The meet-
ing agenda, list of speakers, registered participants and 
presentations are available at https ://WINSi ngapo re201 
8.com.
Welcoming addresses
The first day was opened with welcoming addresses by 
representatives of the National Environment Agency of 
Singapore (NEA), the French Ministry of Foreign Affairs 
in Singapore, the Duke-NUS Medical School of Singa-
pore, and the WHO NTD and TDR departments. All 
speakers acknowledged the need to improve the surveil-
lance and control of arbovirus vectors that also requires 
knowledge of the mosquitoes’ insecticide resistance sta-
tus so that we will be better prepared against existing and 
emerging Aedes-borne disease threats. Dr Julien Pompon 
(Duke-NUS) welcomed participants and presented the 
objectives of the conference. Finally, Dr Vincent Cor-
bel (IRD, France) thanked all sponsors, partners, and 
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supporting organizations that contributed to the organi-
zation of the conference.
Session 1: Control of emerging arboviral diseases
Dr Duane Gubler (Duke-NUS Medical School, Singa-
pore) opened the first session by reviewing the chang-
ing epidemiology of potentially epidemic ABVs and the 
prospects for prevention and control. Beyond dengue, 
chikungunya and Zika, a number of viruses are circulat-
ing such as Japanese encephalitis, Ross River, Rift Valley 
fever, West Nile virus and others. Increased urbanization, 
demographic changes, increasing transportation (4 bil-
lion passengers are estimated to have traveled by air in 
2018), and lack of effective vector control have greatly 
facilitated the movement of these viruses around the 
world [9]. Pandemic yellow fever (YFV) is now seen as 
the next public health threat, as the numbers of cases 
in urban settings have drastically increased in recent 
years [10, 11]. Despite cases being transported around 
the world (with particular concern in the Americas and 
Asia) no local transmission has occurred to date beyond 
Africa. Risk factors for YFV expansion are the low herd 
immunity in humans, encroachment of humans on syl-
vatic cycle, population movement, inadequate vaccine 
supply, and ineffective vector control. As the chairman of 
the Global Dengue & Aedes-Transmitted Diseases Con-
sortium (GDAC), the speaker concluded that the risk of 
epidemic ABVs is the highest in history and encouraged 
the development of a “Global Fund” for ABVs in order to 
build in-country capacity to respond more effectively to 
these threats.
Dr Raman Velayudhan (Neglected Tropical Diseases 
Department, World Health Organization, Switzerland), 
presented the WHO Global Vector Control Response 
(GVCR), which aims to reduce the threat of vector-borne 
diseases through effective locally-adapted vector control 
strategies [2]. The success of this strategy relies on the 
ability of countries to strengthen their vector surveil-
lance and control programmes with enhanced capac-
ity and financial resources. The GVCR strategies need 
to focus on the following key areas: (i) aligning actions 
across sectors, such as ministries of health and other 
relevant ministries and city planners, e.g. for removing 
urban breeding sites; (ii) engaging local communities to 
protect themselves and build resilience against future 
disease outbreaks; (iii) strengthening surveillance to trig-
ger early responses and to identify when and why inter-
ventions are not working as expected; and (iv) scaling-up 
vector-control tools and using them in combination to 
maximize impact on disease. The overall emphasis of this 
programme is to fulfill country and regional needs by 
strengthening vector control programmes through train-
ing and capacity building.
Dr Scott O’Neill (Monash University, Vietnam) pro-
vided an update on the use of the intracellular bacteria 
Wolbachia by the World Mosquito Programme (WMP) 
to disrupt dengue, Zika and chikungunya transmission 
by Aedes aegypti without the need to suppress the mos-
quito population. The aim of the WMP is to introduce 
Wolbachia-infected mosquitoes (male and female) into 
wild mosquito populations to increase the frequency of 
Wolbachia carrying mosquitoes and hence to interrupt 
disease transmission (known as a population replace-
ment strategy) (Fig.  1). Deployment of Wolbachia into 
Ae. aegypti populations can be scaled to areas around 100 
 km2 by releasing approximately 2–5 mosquitoes per per-
son per week [12]. Pilot studies conducted in Townsville 
and Cairns, Australia (in 2005) showed > 90% of locally 
acquired dengue cases after the release of Wolbachia. 
The WMP has developed methods for low-cost, large-
scale application across urban areas in countries affected 
by mosquito-borne diseases. The programme is now 
Fig. 1 Concept of the population replacement strategy using the wMel strain of Wolbachia (Courtesy of the World Mosquito Programme)
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conducting efficacy trials in 11 countries (including Sri 
Lanka, India, Vietnam, Indonesia, Kribati, Vanuatu, Fiji, 
New Caledonia, Mexico, Colombia and Brazil) in order 
to generate data in various epidemiological settings.
Dr Didier Fontenille (Institut Pasteur, Cambodia) gave 
a talk entitled “Arbovirus vectors in South East Asia: a 
plea of ignorance”. Numerous factors such as deforesta-
tion/reforestation, climate change, urbanization, land 
use, pesticide use and human behavior contribute to the 
transmission risk. In Southeast Asia, particularly Cam-
bodia, numerous gaps remain in our knowledge of the 
biology and ecology of arbovirus vectors and those gaps 
will remain as long as there is failure to develop the local 
research facilities and capacities required to address that 
goal. The recent introduction of Ae. albopictus in several 
locations of Phnom Penh and the increasing resistance 
of Ae. aegypti to public health pesticides may compro-
mise vector control efforts. More than 6000 dengue cases 
were declared in Cambodia in 2018. Yellow fever is on 
the rise and the risk of autochthonous transmission in 
Asia-Pacific region has never been so high [13]. Commu-
nity-based participation (COMBI) and innovative tools 
(traps, genetically-modified mosquitoes, Wolbachia) are 
urgently needed to improve the control of invasive mos-
quitoes and to prevent new arbovirus epidemics in the 
region.
Professor Lee Ching Ng (National Environment 
Agency, Singapore) presented progress and limitations 
during the implementation of the “Wolbachia Singa-
pore” project. The National Environment Agency (NEA) 
is evaluating the use of Wolbachia-infected Ae. aegypti 
males with the aim of breaking the dengue transmission 
through vector suppression (Fig. 2). This project relies on 
4 pillars: surveillance; prevention and control; outbreak 
management; and community engagement. The Phase 
1 field study implemented since October 2016 demon-
strated that the released male Wolbachia-infected Aedes 
mosquitoes successfully competed with the urban male 
mosquitoes and were able to mate with the urban female 
mosquitoes. Most of the captured Wolbachia males were 
collected within a short distance from the release point 
but did show a good distribution throughout the area. 
As a result, the releases led to a 50% suppression of the 
urban Ae. aegypti mosquito population in the study sites. 
Since April 2018, NEA is conducting a Phase 2 study 
for improving the release methodologies to mitigate 
the problems presented by Singapore’s high density and 
high-rise urban landscape.
Professor Jeffrey Scott (Cornell University, USA) gave 
an overview of the challenges for controlling insecticide 
resistance in insect vectors of human diseases. In order 
to slow the evolution of resistance, two pieces of informa-
tion are critically important: accurate assessment of the 
phenotype, and methods for the rapid determination of 
the frequency of the mutations that confer resistance in 
field populations. Resistance phenotype is not a binary 
trait and for assessing a phenotypic response in assays we 
need to look beyond evaluations based on a single diag-
nostic dose or concentration. There is also a need for a 
rapid and accurate assessment of the frequency of resist-
ance mutations underlying the phenotypic response. This 
is somewhat simpler for mutations in target site genes, 
but is much more challenging for other major resistance 
mechanisms such as detoxification-mediated resistance. 
Identification of the mutations causing resistance and 
their fitness costs are critical to facilitate understanding 
of the evolution of resistance and to inform resistance 
management strategies.
During the ensuing general discussion, members of the 
audience raised concerns about the deliberate introduc-
tion of insecticide-resistant mosquitoes as a key compo-
nent of the deployment of the Wolbachia technology [14]. 
Indeed, this may favor the survival of released mosquitoes 
in areas where insecticides are in common use and might 
contribute to the spread and homogenization of resistance 
in natural populations. Dr O’Neill stated that the Wol-
bachia-carrying mosquito strain was back-crossed with 
a local strain and that the resistance profile of released 
Wolbachia-mosquitoes simply matched that of the local 
“wild type”. Dr O’Neill encouraged the integration of rou-
tine monitoring of insecticide resistance in future efficacy 
trials with Wolbachia-carrying mosquitoes.
Session 2: Insecticide resistance in arbovirus 
vectors
This session started with talks describing the status and 
spatial distribution of insecticide resistance in arbovirus 
vectors around the globe.
Fig. 2 Concept of the Wolbachia population suppression through 
cytoplasmic incompatibility (Courtesy of Dr L.C. Ng, NEA, Singapore)
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Dr Fara N. Raharimalala (Institut Pasteur, Madagas-
car) presented the insecticide susceptibility status and 
detoxifying enzymes activity in larvae and adults of Aedes 
albopictus in Madagascar. Mosquitoes were sampled in 
six localities (Antananarivo, Toamasina, Farafangana, 
Antsiranana, Mahajanga and Morondava) and then sub-
jected to biological and biochemical assays. All mosquito 
larvae were resistant to temephos. Regarding adults, all 
mosquito populations were susceptible to fenitrothion 
and deltamethrin except those of Antananarivo and 
Mahajanga, respectively. Biochemical studies revealed 
an overproduction of detoxification enzymes (mainly 
esterases and cytochrome P450) that correlated well with 
phenotypic resistance. This study provides the first base-
line information on insecticide resistance in Ae. albopic-
tus in Madagascar. Further investigations are needed to 
address the genetic basis of insecticide resistance in field 
populations.
Dr Sébastien Marcombe (Institut Pasteur, Lao PDR) 
investigated the status, distribution and mechanisms of 
insecticide resistance in dengue vectors in Laos. Routine 
monitoring surveys conducted in 12 provinces showed 
moderate to high temephos resistance in Ae. aegypti and 
Ae. albopictus. Based on that finding, the National Stra-
tegic Plan 2019 for dengue control has been revised to 
stop using temephos and adopt a rotation scheme based 
on Bti, spinosad, and diflubenzuron. Adult bioassays 
showed resistance to malathion (organophosphate) and 
DDT (organochlorine) in Ae. aegypti and Ae. albopic-
tus. Aedes aegypti also showed resistance to permethrin 
and deltamethrin. Biochemical assays showed higher 
activities of esterases and oxidases in natural populations 
compared to the susceptible USDA strain. Copy number 
variants (CNV) affecting the carboxylesterase CCEAE3A 
and the cytochromes P450 CYP6BB2 and CYP6P12 were 
detected by qPCR and were significantly correlated with 
insecticide resistance. In contrast, no clear association 
between the frequency of kdr mutations, for both 1534C 
and 1016G, and the mosquito survival rate to DDT and 
permethrin was observed. Altogether, these results dem-
onstrate that metabolic-based resistance plays a major 
role in insecticide resistance in Ae. aegypti in Laos. These 
findings have important implications for dengue vector 
control and highlight the urgent need to identify new 
insecticides and innovative strategies to fight against 
arboviruses vectors.
Dr João Pinto (Instituto de Higiene e Medicina Tropi-
cal, Portugal) reported the origin and insecticide sus-
ceptibility status of a recently introduced Ae. albopictus 
population from Portugal. During the summer of 2017, 
two independent introduction events of the invasive 
mosquito Ae. albopictus were reported in Portugal from 
Hotel resorts located in Penafiel, Porto and Vilamoura, 
Faro. A preliminary analysis of 16 microsatellite loci sug-
gest two independent origins for the introductions of Ae. 
albopictus in north and south of Portugal [15]. Bioassays 
carried out on the F1 generation showed full susceptibil-
ity of Ae. albopictus to permethrin (0.25%), deltamethrin 
(0.03%), cyfluthrin (0.15%), and fenitrothion (1%), and 
suspected resistance to bendiocarb (1%) according to 
WHO criteria [16]. It is important to continue mosquito 
surveillance and insecticide resistance monitoring to pre-
vent the establishment and spread of invasive mosquitoes 
in Portugal.
Dr Ademir Martins (FIOCRUZ/IOC, Brazil) started 
by describing the Insecticide Resistance Monitoring Pro-
gramme conducted in Brazil after the Zika outbreak. Pre-
vious monitoring studies (1999–2013) conducted in 102 
sentinel municipalities have shown high resistance of Ae. 
aegypti to temephos and deltamethrin. Since then, the 
country reported more than 60 and 75% of probable cases 
of dengue and chikungunya, respectively in 2016, and 
more than 20% of Zika cases reported in the Americas so 
far. To guide decision making for vector control, the larg-
est countrywide insecticide resistance monitoring (IRM) 
programme to date has been implemented by the dengue 
national control programme coordinated by the Ministry 
of Health (MoH). In total 146 municipalities were elected 
for sampling during 2017–2018, and the eggs shipped to 
two reference laboratories, where diagnostic dose bioas-
says with pyriproxyfen and malathion being performed, 
as well as kdr genotyping. The results will help the MoH 
to implement targeted chemical control of Ae. aegypti in 
the country.
Dr Nelson Grisales (Abt Associates, USA) described 
the Zika AIRS Project (ZAP) funded by USAID that aims 
to implement systematic insecticide resistance monitor-
ing for Aedes mosquitoes in seven Latin American and 
Caribbean countries previously affected by Zika (i.e. 
Guatemala, Honduras, El Salvador, Paraguay, Guyana, 
Jamaica and the Dominican Republic). The ZAP builds 
systems, technical capacity, and promote appropriate 
resourcing in support of insecticide resistance testing in 
each country. After having reviewed the gaps and chal-
lenges for strengthening country capacity in entomologi-
cal surveillance, the ZAP has developed a comprehensive 
approach to institutionalizing resistance testing accord-
ing to the country needs that is (i) training of skilled 
staff, (ii) establishment of high quality entomology labo-
ratories; and (iii) raising awareness on the importance of 
resistance testing. Although challenges remain, impor-
tant elements are now in place to provide a foundation 
for sustained insecticide resistance testing in the region.
Dr David Weetman (Liverpool School of Tropical Med-
icine, UK) described the work performed by the WIN 
community to review available evidence on the spatial 
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distribution of Aedes insecticide resistance and underly-
ing mechanisms. About 6900 bioassay data points were 
collected and overall, 57 countries (87% of the total) 
showed confirmed or suspected resistance to at least one 
insecticide [4]. Resistance to all four main public health 
pesticides classes (pyrethroids, organophosphate, carba-
mates and organochlorines) is present in the Americas, 
Africa and Asia but distributions are not homogeneous, 
suggesting both challenges and opportunities for resist-
ance management. Overexpression of resistance-asso-
ciated detoxification enzymes appears widespread, and 
likely involves many genes. Estimating insecticide resist-
ance is currently being challenged by a lack of standardi-
zation and diagnostic doses, but could be greatly assisted 
by calibration and predictive application of existing and 
novel DNA diagnostics for resistance. Widespread resist-
ance calls for the careful use of existing formulations and 
implementation of insecticides with alternate modes of 
action.
The following presentations were dedicated to the 
understanding of resistance-associated molecular mech-
anisms; the evaluation of the impact of resistance on vec-
tor control; and the development of insecticide resistance 
management strategies for arbovirus vectors.
Dr Jean-Philippe David (Centre National de la 
Recherche Scientifique, Grenoble, France) presented the 
advantages of using an integrated approach combining 
experimental evolution, quantitative genetics and next-
generation sequencing to identify novel genetic mark-
ers of insecticide resistance in the dengue mosquito Ae. 
aegypti. Whilst there are well-established markers for 
target-site mechanisms, reliable markers for metabolic 
resistance remain rare. Recently, deep targeted DNA-
sequencing successfully identified several copy number 
variations (CNV) affecting cytochrome P450s (Cyp6 
& Cyp9 families) that were associated with deltame-
thrin resistance [17]. The number of CNV was signifi-
cantly correlated with increased gene expression levels 
obtained from RNA-seq [18]. Molecular investigations 
of Ae. aegypti samples from Laos showed that genomic 
amplification of an esterase cluster previously associ-
ated with temephos resistance in larvae was also strongly 
associated with adult resistance to malathion. These find-
ings demonstrate that CNVs are promising DNA mark-
ers for tracking metabolic resistance because (i) they are 
frequent in Ae. aegypti, and (ii) they showed good asso-
ciation with resistance phenotype. These results pave the 
way for the development of novel diagnostic tools able to 
concomitantly track the whole range of insecticide resist-
ance mechanisms in order to improve resistance moni-
toring and management.
Dr Shinji Kasai (National Institute of Infectious Dis-
eases, Japan) described the first occurrence of the 
knockdown resistance (kdr) allele V1016G in Ae. albopic-
tus in Asia and Europe. Overall, 30 Ae. albopictus popula-
tions were collected in Vietnam, Italy, Singapore, Brazil 
and Taiwan. Bioassays revealed that most populations 
of Ae. albopictus were highly susceptible to permethrin 
but a few from Italy, Vietnam and Singapore, exhibited 
resistance. Genotyping studies detected the kdr alleles 
F1534C in Vietnam and Singapore and F1534S in Viet-
nam and V1016G in samples from Vietnam and Italy for 
the first time in history [19]. Establishment of colonies 
homozygous for each kdr allele showed that 1016G allele 
caused much greater levels of pyrethroid resistance (5- 
to 13-fold) than 1534C or 1534S. The occurrence of the 
V1016G kdr mutation in the tiger mosquito represents a 
new threat to the control of this species worldwide.
Mrs Erly Sintya Dewi (Universitas Warmadewa, Indo-
nesia) presented the status of insecticide resistance of Ae. 
aegypti in the Indonesian island of Bali and its implica-
tions for dengue control. WHO tube tests carried out on 
field-caught Ae. aegypti mosquitoes showed low mortal-
ity rates when exposed to diagnostic concentrations of 
permethrin (5% mortality), alpha-cypermethrin (14% 
mortality) and to a lesser extent, malathion (60% mortal-
ity). Mosquitoes surviving permethrin exposure exhib-
ited higher frequencies of kdr S989P and V1016G alleles 
than those killed [20]. Genome-wide variation analyses 
showed a decrease of diversity around the VGSC gene 
locus, indicating a selective sweep. The use of “free-flight” 
tests in patchily treated rooms demonstrated that the Bali 
strain was far less affected by permethrin (48% mortal-
ity) than the susceptible Australian Ae. aegypti strain 
used as a reference (94% mortality). Under similar condi-
tions, malathion killed 100% of both Aedes strains. This 
study demonstrates that insecticide resistance may com-
promise dengue vector operations relying on pyrethroids 
and the use of malathion represents the most pragmatic 
choice for the control of Ae. aegypti in Bali.
The presentation of Dr Gabriela Gonzalez-Olvera 
(Universidad Autónoma de Yucatán, Mexico) focused 
on the impact of household aerosolized insecticides on 
pyrethroid-resistant Ae. aegypti. Mismatch between the 
frequency of pyrethroid resistance in mosquitoes and 
the occurrence of pyrethroid-based insecticide appli-
cations for vector control has been observed in many 
places in Latin America [21] and could be due to the 
intense household use of commercial insecticide prod-
ucts. Through experimental assays quantifying pheno-
typic and genotypic responses of mosquitoes exposed to 
commonly used household aerosols, the authors showed 
significantly lower mortality rates (40–50%) of three 
pyrethroid-resistant field Ae. aegypti strains compared to 
the laboratory susceptible strain (99%). Applying insec-
ticides as surface sprays led to a significant increase in 
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the frequency of kdr V1016I homozygotes in surviving 
Ae. aegypti, suggesting strong selection pressure for this 
allele [22]. Given the large-scale use of household aero-
sol insecticide products in areas that are endemic for Ae. 
aegypti-transmitted diseases, their role in selecting pyre-
throid resistance, should be taken into consideration 
when designing resistance management plans.
Dr Gregor Devine (QIMR Berghofer, Australia) talked 
about the problem of dispersion of invasive vectors 
facilitated by the global movement of people and cargo 
by aeroplanes and reviewed the WHO procedures for 
aircraft disinsection [23]. In Australia, disinsection pro-
cedures for aircraft entering the country are increas-
ingly reliant on the residual treatment of cabins and 
holds with 200 mg/m2 permethrin applied at 8-week 
intervals. The impact of pyrethroid resistance on the 
efficacy of permethrin residual application has however 
never been explored. Through a series of bioassays con-
ducted on a range of treated aircraft surfaces and highly 
permethrin-resistant Ae. aegypti strains (homozygous 
for 989P and 1016G), the author showed very poor 
efficacy of permethrin, particularly on carpets and 
seat covers (0–10% mortality). This was the result of 
insecticide resistance and the poor bioavailability of 
permethrin on absorptive surfaces (as confirmed by 
high-performance liquid chromatography, HPLC). The 
24 h exposure of insecticide-resistant, free-flying mos-
quitoes to patchily-applied residues in a 20  m3 flight 
chamber resulted in < 25% of the mortality seen for 
insecticide susceptible mosquitoes. In contrast, mala-
thion at 2 g/m2 was effective against those resistant 
strains, so alternative chemistries, although not regis-
tered for use on aircraft, may still be used “ground side” 
to protect passenger disembarkation and baggage han-
dling areas. New disinsection chemistries and applica-
tion methods are needed to protect Australian borders, 
communities and the insecticide-susceptibility of local 
endemic mosquito populations.
This session ended with a presentation from Dr 
Fabrice Chandre (Institut de Recherche pour le Dével-
oppement, France) about insecticide resistance man-
agement (IRM) strategies applicable to mosquito 
vectors of arboviruses [24]. This work coordinated by 
the Worldwide Insecticide Resistance Network (WIN) 
aimed at defining the principles and concepts underly-
ing IRM, identifying the main factors affecting the evo-
lution of resistance and evaluating the value of existing 
tools for resistance monitoring (Fig.  3). Based on the 
lessons taken from resistance management strategies 
used for other vector species and agricultural pests, 
the speaker emphasized on the need for urgent action 
to contain insecticide resistance in invasive mosquitoes 
Fig. 3 Management of insecticide resistance in Aedes vectors. Factors contributing to the selection of insecticide resistance in mosquitoes (left 
panel). Conceptual framework for implementing IRM in Aedes (right panel) (Copyright: Creative Commons Attribution 4.0 License (https ://creat iveco 
mmons .org/licen ses/by/4.0/). Citation: Dusfour et al. (2019) Management of insecticide resistance in Aedes vectors: advances and challenges. PLoS 
Negl Trop Dis. 2019 (In Press) [24])
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and proposed a roadmap for the implementation of a 
global plan for IRM in Aedes mosquitoes.
Session 3: Innovative vector control approaches 
for emerging arboviruses
This morning plenary session started with five presenta-
tions on control strategies and new tools for improving 
Aedes control and surveillance.
Professor Dina Fonseca (Rutgers University, USA) 
opened this session by presenting a “success story” for 
the control of Aedes mosquitoes through a “Citizen 
Action through Science” (Citizen AcTS) approach that 
engages community members to perform mosquito con-
trol in their yards. This approach was tested in a NE US 
town of approximately 1000 residential yards infested 
with the invasive Asian tiger mosquito, Ae. albopictus 
[25]. After consulting with Rutgers entomologists, mem-
bers of the community purchased, deployed and main-
tained 1032 Gravid Aedes Traps (GATs) two per yard out 
of 954 potential yards (46%) starting in June of 2017. To 
assess the effectiveness of the intervention during August 
and September a team from Rutgers deployed BG Senti-
nel traps in 19 yards across the town. They found that a 
GAT coverage higher than 80% in neighborhood clusters 
resulted in significant decreases in host-seeking female 
Ae. albopictus. This community-based approach works 
through respectful exchanges among scientists and resi-
dents that lead to trust and individual ‘buy-in’. Results of 
the surveys were quickly provided to the residents at the 
end of the season and have helped maintain the interest 
and enthusiasm.
The development of a new gravid trap for mosquito 
surveillance and control in Singapore was the cen-
tral topic of the presentation by Dr Chee-Seng Chong 
(Environmental Health Institute, National Environment 
Agency (NEA), Singapore & Nanyang Technological Uni-
versity, Singapore). The Gravitrap is a black cylindrical 
contraption that contains aged hay infusion as a lure to 
attract female Aedes mosquitoes that are seeking water 
containers to lay their eggs. Gravitraps were placed in 
2013 in 580 residential blocks within 34 sentinel loca-
tions to address the spatial dynamics of Aedes population 
[26]. After 5 years, 50,000 datapoints were recorded for 
resource prioritization. The results show that Aedes mos-
quitoes were heterogeneously distributed among blocks 
and among floors within the block. The abundance of 
Ae. aegypti was positively associated with the age of the 
blocks. A before-after-control-impact (BACI) analysis 
to compare the dengue-case ratio between estates with 
and without Gravitraps indicated a 30% reduction in case 
burden in estates with Gravitraps. Beyond providing spa-
tial and temporal data on vector risk, the direct removal 
of the adult females by Gravitraps deployed in public 
housing has shown to have an epidemiological impact.
Dr Alongkot Ponlawat (Vector Biology & Control Sec-
tion, Department of Entomology, USAMD-AFRIMS, 
Thailand) presented an overview of new vector control 
tools (VCTs) under investigation in Thailand. Labora-
tory experiments showed that blood-fed females of Ae. 
aegypti exposed to pyriproxyfen (PPF) had significantly 
less fecundity and fertility than unexposed females. 
Pre-exposure to PPF also reduced sperm production in 
males. A field trial involving 11 clusters in Muang Dis-
trict, Bangkok showed that clusters sprayed with the 
combination of pyrethrin and PPF (ULV or thermal fog-
ging) had significantly lower numbers of Ae. aegypti 20 
days post-application than the control (unsprayed clus-
ter). These findings suggest that IGRs alone or combined 
with a pyrethroid adulticide may contribute to effective 
control of Aedes mosquitoes in Thailand.
Dr Sebastian Boyer (Institut Pasteur du Cambodge, 
Cambodia) presented results of a cluster randomized 
controlled trial aiming at evaluating an integrated vec-
tor control strategy (IVCS) targeting schools to pre-
vent dengue and dengue-like syndrome (DLS). The trial 
was implemented in Kampong Cham Province, Cam-
bodia with 24 clusters, 12 under integrated vector con-
trol and 12 without. Each cluster included one school, 
with an active surveillance of DLS in neighbouring vil-
lages (~15,000 children aged 5–15 years-old). The IVCS 
implied the removal of breeding sites in and around the 
school, the use of the bacterial insecticide Bti in perma-
nent domestic water containers, deployment of In2care® 
traps for the dissemination of pyriproxyfen and spores of 
Beauveria bassiana and education and sensitization of 
children. Entomological preliminary data during the sec-
ond year, following interventions, showed a 50% decrease 
in Ae. aegypti relative abundance in treated clusters com-
pared to untreated clusters. Similarly, except for one 
school, there was a strong decrease in positive contain-
ers in all houses around the schools. Although epidemio-
logical data acquisition is still in progress, first serological 
surveys showed fewer DLS in the treated (n = 485) than 
in the control cluster (n = 165), suggesting that IVM for 
dengue prevention worked well in schools.
Dr David Roiz (IRD, MIVEGEC, France) presented 
a framework for the implementation of an integrated 
Aedes management (IAM) for the control of Aedes-borne 
diseases [3]. IAM has been developed by the WIN net-
work to provide national authorities with a compre-
hensive evidence-based guidance on how and when to 
implement Aedes control measures. IAM consists of a 
portfolio of operational actions and priorities for the con-
trol of Aedes-borne viruses that are tailored to different 
epidemiological and entomological risk scenarios. The 
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framework has four activity pillars: (i) integrated vector 
and disease surveillance, (ii) vector control, (iii) com-
munity mobilisation, and (iv) intra- and intersectoral 
collaboration; and four supporting activities: (i) capac-
ity building, (ii) research, (iii) advocacy, and (iv) policies 
and laws (Fig.  4). IAM supports the implementation of 
the WHO Global Vector Control Response that aims to 
devise and deliver sustainable, effective, integrated, com-
munity-based, locally adapted vector control strategies 
in order to reduce the burden of vector borne diseases 
worldwide.
Dr Nicole Achee (Notre Dame University, USA) gave a 
general overview of alternative strategies for mosquito-
borne arbovirus control. The alternative strategies that 
have been presented reflect those that are currently 
under evaluation for public health value by WHO and 
various stakeholders and included novel larvicides/
applications, spatial repellents, traps, attractive targeted 
sugar baits (ATSB), insecticide-treated materials, ster-
ile insect technique (SIT), release of insects with domi-
nant lethality (RIDL), Wolbachia and synthetic gene 
drive methods. Overall, the speaker described when and 
where these strategies/products may offer the greatest 
public health value [6]. Considerations to deployment, 
regulations, community acceptance, and sustainabil-
ity were discussed. Although evidence is still lacking for 
most of these interventions, they may offer great poten-
tial for mitigating insecticide resistance, through an IVM 
approach, even if it is of a similar efficacy to existing 
interventions.
Dr Devi Shankar Suman (Ministry of Environment, 
India) gave an overview of insecticide-auto-dissemi-
nation technologies for mosquito control. The auto-
dissemination strategy exploits the skip-oviposition 
behaviour of gravid females transferring small insecti-
cide doses in an eco-friendly manner among breeding 
habitats [27, 28]. This approach is particularly interest-
ing for Aedes mosquitoes that inhabit a wide range of 
artificial water containers and cryptic habitats in urban 
and suburban areas, that are difficult to control with 
conventional treatments [29]. The efficacy of locally 
made autodissemination stations using pyriproxyfen, 
an insect growth regulator and oviposition attract-
ants were tested in residential areas infested with Ae. 
Fig. 4 Conceptual framework of implementing an Integrated Aedes management for the control of Aedes‑borne diseases (Copyright: Creative 
Commons Attribution 4.0 License (https ://creat iveco mmons .org/licen ses/by/4.0/). Citation: Roiz et al. (2018) Integrated Aedes management for the 
control of Aedes‑borne diseases. PLoS Negl Trop Dis. 2018;12:e0006845 [3])
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albopictus in New Jersey, USA [30]. The results showed 
that the stations effectively delivered pyriproxyfen in 
cryptic habitats where insecticides could not penetrate 
using conventional insecticide sprayers. Autodissemi-
nation stations significantly reduced the numbers of 
eggs, larvae and adult mosquitoes and hence represent 
promising alternative tool for the control of container-
breeding mosquitoes.
Professor Gregor Devine (QIMR Berghofer, Australia) 
presented a talk on targeted indoor residual spraying 
(TIRS) for the control of Ae. aegypti. TIRS consists of 
spraying walls below 1.5 m and dark areas under furni-
ture that are the favorite resting places for Ae aegypti. 
A retrospective study of public health GIS data from 
Cairns, Australia showed that contact tracing coupled 
with TIRS (lambdacyalothrin) around case residences 
and their potential exposure locations reduced the prob-
ability of future DENV transmission by 86–96%, com-
pared to unsprayed premises [31]. The residual efficacy 
of conventional IRS against two TIRS methods using 
a carbamate insecticide against a pyrethroid-resistant, 
field-derived Ae. aegypti strain was further evaluated in 
Merida, Mexico. A clustered randomized control trial 
showed that TIRS and Resting-Site-IRS took 31% and 
82% less time to apply, respectively, and used 38% and 
85% less insecticide, respectively, than conventional IRS. 
The mortality of pyrethroid-resistant Ae. aegypti did not 
differ significantly among the three IRS application meth-
ods for up to two months post-application, and did not 
significantly differ between conventional IRS and TIRS 
up to four months post-application. These data illustrate 
that optimizing IRS to more efficiently target Ae. aegypti 
can both reduce application time and insecticide volume 
without reducing entomological efficacy.
Dr David Damiens (Institut de Recherche pour le 
Développement-CYROI, La Réunion Island, France) pre-
sented new developments in the use of the sterile insect 
technique (SIT) for Ae. albopictus control in La Réunion 
Island. From 2009 to 2014, the researchers developed a 
cost-effective adult holding cage for mass rearing that 
offers several advantages including weekly egg produc-
tion of 250,000-400,000 eggs/cage, higher egg hatch rates 
and similar survival rate to the reference FAO/IAEA 
cage. Furthermore, they showed that irradiated ster-
ile males demonstrated similar mating success as fertile 
males [32]. The second phase of the project will focus on 
field site characterization (in terms of spatial and tempo-
ral distribution of the mosquito population) and social 
mobilization and communication for the release of sterile 
mosquitoes at two pilot sites on the island.
Mr Kyrou Kyros (Imperial College, London, UK) 
closed the session with a talk on gene drive technology 
for vector control. The recent development of CRISPR/
Cas9 has unlocked the possibility to selectively edit a 
Fig. 5 Gene drive inheritance concept. Gene drives copy themselves onto both chromosomes so the modified chromosome is inherited by all of 
the offspring (Courtesy of Mr Kyros Kyrou)
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mosquito population with the goal of developing a novel 
vector control strategy (Fig. 5). Current genetic modifica-
tions designed to either impair female fertility or inter-
fere with mosquito ability to transmit a malaria parasite 
have been shown to spread within large caged mosquito 
populations. In the laboratory, the team showed very 
strong transmission rates (up to 100%) into the progeny 
of three driven genes (AGAP005958, AGAP011377 and 
AGAP007280) which target female reproduction [33]. 
When AGAP007280 was tested in a population experi-
ment, the spread proceeded as predicted for four genera-
tions but unfortunately, successive loss of the gene was 
reported from generation 8, hence indicating resistance 
to the drive. In contrast, a new CRISPR-Cas9 gene drive 
construct targeting the gene doublesex (Agdsx) of An. 
gambiae spread rapidly in caged mosquitoes, reaching 
100% prevalence within 7–11 generations while progres-
sively reducing egg production to the point of total popu-
lation collapsed [34]. Given the conserved functional role 
of dsx for sex determination in all insect species and the 
high degree of sequence conservation amongst members 
of the same species, there is a potential of this gene drive 
system for targeting other vector species including Aedes 
taxa.
The session ended with an open discussion highlight-
ing the promising results obtained in the development 
of new technologies and tools for mosquito control 
but acknowledging that evidence is still lacking to sup-
port their massive deployment by national control pro-
grammes. Questions were raised about the operational 
impact of gene drive technologies for controlling wild 
mosquito populations. Mr Kyros indicated that the 
potential of gene drive systems for field applications will 
be further evaluated as part of a phased approach in large 
confined spaces that mimic real ecological conditions 
more closely, in accordance with the recommendations of 
the USA American National Academy of Sciences.
Session 4: Private/public initiatives to foster 
innovation in public health
This session aimed to discuss the challenges of insecti-
cide resistance in the context of developing new tools, 
norms, and regulations for vector control. Representa-
tives of the agrochemical sector from 12 companies, 
IVCC and other global initiatives (I2I, VectorBase, etc.) 
attended the conference to present on going activities, 
strategies and opportunities for improving vector-borne 
diseases control.
In the first session, five presentations were given by 
representatives of private companies that are involved in 
private-public partnerships for the development of inno-
vative solutions for vector control.
Mr Peter DeChant (Valent BioSciences LLC, USA) 
presented IVM programmes relying on the use of Bacil-
lus thuringiensis var. israelensis (Bti) strain AM65-
52. Bti AM65-52 (Sumitomo Chemicals) has a unique 
mode of action, producing several cry toxins which in 
combination have high potential for resistance manage-
ment [35]. Mr DeChant provided an overview of three 
observational studies conducted in Cambodia, Malay-
sia and Florida Keys, USA showing a strong impact of 
wide area application of Bti AM65-52 on the reduction 
of Ae. aegypti abundance and both dengue and Zika 
transmission [36–38]. Integration of Bti AM65-52 into 
operational programmes offer interesting prospects to 
prevent future outbreaks and to preserve the lifespan 
of current insecticidal chemistries, which are at-risk of 
operational failure due to resistance.
Mr Jason Nash (Bayer, Singapore) focused on Fludora 
Co-Max®, a new space spray combination for mosquito 
resistance management programmes. The rationale for 
developing this product was to look at active ingredi-
ents originally developed for agriculture that meet the 
requirements to be used in public health. This formu-
lation combines two active ingredients with different 
modes of action (i.e. flupyradifurone, a butenolide, and 
transfluthrin, a pyrethroid) to enhance the control of 
insecticide resistance mosquitoes. Outdoor vehicle-
mounted ULV spray in the USA and Brazil showed 
optimal control of insecticide-resistant Aedes mosqui-
toes (100% mortality) up to 100 m distance from spray 
origin. Fludora Co-Max® has a flexible use, being suit-
able for ULV, cold/hot fogging, and outdoor/indoor 
application and represents a promising technology for 
vector control and insecticide resistance management.
Mr Iñigo Garmendia (Goizper Spraying, Spain) 
started his presentation by providing the advantages 
of using IRS for the control of indoor biting/resting Ae. 
aegypti [39]. The efficacy of IRS actually depends on 
many operational factors including the quality of the 
spray. The speaker then described the performances of 
a new “iK vector control super sprayer” intended for 
indoor applications of insecticides. This new device has 
significant improvements over other devices, includ-
ing the reduction of insecticide deposit variation on the 
wall through a constant nozzle flow rate, 50% reduction 
of insecticide loss, reduction of nozzles erosion over 
time, and reduction of contamination risk.
Mr Siao Jing Sam (Syngenta, Singapore) talked about 
Actellic 300CS, an organophosphate formulation for 
long-lasting IRS. This consists of an innovative micro-
encapsulated formulation of pirimiphos-methyl (PM) 
that is expecting to deliver long-lasting residual control 
of mosquitoes (> 7 months) on porous surfaces. Several 
field studies are on-going in Africa to investigate the 
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efficacy of Actellic 300CS in reducing mosquito biting 
rate and malaria transmission. Although some resist-
ance to PM has been suspected in malaria vectors in 
some part of West Africa [40] Actellic 300CS has the 
potential for resistance management, either in rotation 
or mixture, with the aim to reduce the selection pres-
sure by pyrethoids.
Dr James Austin (BASF, USA) addressed the potential 
of using non-repellent chemical insecticides for dengue 
management. Several solutions exist for dengue control 
and include indoor spraying, lethal oviposition traps, 
insecticide house screens, netting solutions, or applica-
tions of insecticides underneath furniture [41–45]. Chlo-
rfenapyr (CFP), a repurposed insecticide from agriculture 
belonging to the pyrrole class has been evaluated in Aus-
tralia for its potential use as an IRS. Phantom insecticide 
and Phantom pressurized insecticide have provided 100% 
control of Ae. aegypti mosquitoes in lab trials. Cone bio-
assay data 3 months after application of CFP at a rate of 
250 and 500 mg/m2 on variable substrates showed 100% 
mortality of Ae. aegypti after 2-h exposure and 72-h hold-
ing period. Greater susceptibility of mosquitoes to CFP 
was observed when host-seeking and circadian rhythms 
were considered. Altogether these findings suggest that 
CFP is a promising chemical for Aedes control.
The second part of this session presented current ini-
tiatives and partnerships developed to foster innovation 
in vector control and resistance management as well as to 
accelerate a streamlined evaluation of pesticide products.
Dr Angus Spiers (Innovation to Impact, i2i, UK) dis-
cussed the actions that i2i launched in 2013 to promote 
innovation and accelerate the impact of new tools (https 
://innov ation toimp act.org/). Since the inception of i2i, 
this partnership has engaged a range of stakeholders 
encompassing the gamut of vector control partners to 
implement significant changes to the evaluation of vector 
control tools, most notably with the transition of WHO 
product evaluation from WHOPES to the WHO Pre-
qualification Team (WHO-PQT) and the requirement for 
data to be produced at GLP certified sites. Currently 17 
sites, 4 in Latin America, 6 in Asia, and 7 in Africa are 
included in the GLP accreditation process. i2i also tries 
to maximize impact at national level by speeding up 
country access to vector control tools and by minimiz-
ing the delay between WHO-PQT listing and registration 
by national regulatory authorities. Dr Spiers discussed 
remaining issues to be resolved to further optimize the 
evaluation and deployment of new vector control tech-
nologies such as lack of public health evidence for new 
tools, heterogeneity in regulatory pathways, and lack of 
quality control.
Mr Dominic Schuler (WHO-PQT, Switzerland) pre-
sented an update of the Prequalification Team for 
Vector Control (PQT-VC) at WHO (https ://www.who.
int/pq-vecto r-contr ol/en/). WHO’s function for the 
evaluation of public health pesticides was transitioned 
from WHOPES to PQT in 2017 in order to harmonize 
approaches with the existing PQ product evaluation 
streams of medicines, vaccines, and diagnostics. The 
mandate of PQT-VC is to increase access to safe, high 
quality, efficacious vector control products. The first pri-
ority was to ensure vector control product “conversions” 
from WHOPES recommendations to PQT listing and to 
conduct inspections assessing the production facilities’ 
ability to produce vector control products. To date, 9 
inspections have been conducted and 14 inspections are 
planned by the end of the 2019. PQT-VC currently works 
on label improvement to ensure that efficacy claims are 
supported by robust evidence and is evaluating 7 new 
submissions, including PBO LLINs.
Dr Nick Hamon (IVCC, UK) presented the develop-
ment of a toolbox of solutions that can be deployed as 
part of an integrated vector management programme 
with the aim to control or even eliminate vector-borne 
diseases. IVCC is a product development partnership 
(PDP) that works with funders, innovators, academic 
groups, testing facilities, and international organizations 
to develop new solutions for vector control (http://www.
ivcc.com/). IVCC has supported the development and 
launch of several new tools for tackling malaria vectors 
and has major collaborative projects with leading compa-
nies for the development of novel insecticide active ingre-
dients for use in public health and the adoption of new 
resistance-breaking products through the IVCC NgenIRS 
programme funded by Unitaid. This programme, involv-
ing next generation products for indoor residual spray-
ing, is now active in 18 African countries and is due to 
be followed up with a similar approach to support the 
introduction of novel LLINs. With the support of the Bill 
& Melinda Gates Foundation, DFID, USAID, DFAT, SDC 
and Unitaid, IVCC continues exploring a diverse range of 
emerging products and technologies for vector control, 
including Aedes vectors (e.g. electronic barriers, RNAi 
insecticides, “intelligent traps”, etc.).
Dr Florence Fouque (WHO-TDR, Switzerland) pre-
sented the legislative framework for vector control, 
with a focus on European countries. At the global 
level, countries which have agreed and signed the 
WHO International Health Regulations (IHR) docu-
ment are recognizing some definitions and obligations 
on vectors of infectious agents constituting a public 
health risk, vector surveillance and control activities 
[46]. The absence of a harmonized legislative frame-
work for implementation of vector-related activities at 
region or country level is posing problems not only for 
responding to emergency across borders, but also for 
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testing and deploying new VCTs, such as traps, biologi-
cal organisms and/or genetically modified organisms 
(GMO). For most EU countries, vector surveillance and 
control are under the Ministry of Health, but vector 
control products are under both Ministry of Health and 
Ministry of Environment, with authorizations based on 
EU legislation (Biocidal Products Directive 98/8EC). 
New vector control technologies using GMO, such as 
mosquitoes hosting Wolbachia sp. bacteria through 
transfection, have to be discussed under the rules of the 
Cartagena Protocol [47]. For most other countries, the 
tools using GMO do not have the adequate legislation 
to authorize large-scale testing. Consequently, there is 
a strong need for a global and harmonized legislative 
framework for vector-related activities.
Dr Samuel Rund (Notre Dame University, USA) 
described the PopBioMap by VectorBase.org, an online 
resource for insecticide resistance data that was devel-
oped by Notre Dame University, Imperial College Lon-
don and EMBL-EBI with financial support from NIH 
(https ://www.vecto rbase .org/popbi o/map/). The Pop-
BioMap module has been created to respond to the 
emergence and spread of insecticide resistance in mos-
quitoes of public health importance. The PopBioMap 
is a graphical, map based, online tool for visualizing 
available information on the prevalence and mecha-
nisms of insecticide resistance in vectors as well as 
surveillance data such as species, abundance, pathogen 
infections, etc. Data are submitted directly by research-
ers or extracted from publications by the VectorBase 
curators. The module contains significant amounts of 
genotypic and phenotypic data for major mosquito taxa 
(i.e. Anopheles, Culex and Aedes) helping national pro-
grammes to implement more effective, locally adapted 
vector control.
Dr Vincent Corbel (Institut de Recherche pour le 
Développement, France) closed this session by pre-
senting the missions of the WIN. WIN is supported by 
the WHO Special Programme for Research and Train-
ing in Tropical Diseases (TDR) and the Department of 
Neglected Tropical Diseases (NTDs) since 2016 [7]. It 
brings together 19 internationally recognized insti-
tutions to track and combat insecticide resistance in 
arbovirus vectors worldwide (http://win-netwo rk.ird.
fr/). Since its creation, the WIN has published 6 review 
papers to fill knowledge gaps on topics related to vec-
tor resistance and IVM and has organized biannual 
international conferences to foster innovation and 
strengthening mosquito control and surveillance efforts 
worldwide [8]. The network has gained international 
recognition for its role in mosquito resistance and is 
now expanding to a membership organization aiming 
at gathering all actors involved in vector-borne disease 
control (i.e. academia, international organizations, 
NGOs, not for profit organization, and the private sec-
tor). The ultimate goal of WIN is to build a global part-
nership to support international efforts to reduce the 
global burden of ABVs by 2030.
Reports from Round Tables
Round Table 1: Are the sustainable development goals 
(SDGs) for dengue and other arboviral diseases achievable 
with existing vector control tools?
The SDGs are a collection of 17 global goals set by the 
United Nations as part of Resolution 70/1 “Transform-
ing our World: the 2030 Agenda for Sustainable Devel-
opment” adopted in September 2015. The SDGs build 
on the success of the Millennium Development Goals 
(MDGs) and aim to go further to end all forms of pov-
erty. Specifically, Target 3.3 aims to end the epidemics 
of AIDS, tuberculosis, malaria and neglected tropical 
diseases and combat hepatitis, water-borne diseases and 
other communicable diseases by 2030. Among commu-
nicable diseases, vector-borne diseases (VBDs) account 
for 17% of the global burden [2]. The WHO global vector 
control response, recently endorsed by member states, 
targets a reduction in mortality through VBDs by at least 
75% by 2030. The question debated was “Are existing 
VCTs sufficient to reduce the burden of VBDs and espe-
cially ABVs and if not, what are the gaps that need to be 
addressed to achieve that goal?”
Workshop members agreed that examples of using 
existing VCTs to control ABV outbreaks do exist. These 
successes were predominately through operational 
impact using integrated approach of indoor and perifocal 
residual spraying, larval source reduction/treatment and 
social campaigns to reduce Ae. aegypti populations and 
dengue cases during the 1950s in Brazil, the 1970–1980s 
in Singapore and Cuba, among other examples. However, 
control failed primarily due to inability of systems to sus-
tain these organized VC efforts [6].
Challenges to achieving success with existing VCTs 
continue and are dynamic. Evolving demographics (e.g. 
urbanization, lifestyles) and community/individual 
empowerment represent different conditions to that 
during the Aedes eradication era where VC implementa-
tion was largely dictatorial. WIN workshop participants 
acknowledged a general ‘resistance’ by populations and/
or countries on chemical use that has facilitated mainte-
nance of ABV exposure and therefore the risk of infec-
tion. Coverage remains a challenge for existing VCTs as 
not all larval and/or adult habitats can be easily accessed. 
Optimization of delivery systems may offer improve-
ments to such coverage gaps. Similarly to existing tools, 
alternative VCTs will likely face many similar chal-
lenges. For example, implementation must be culturally 
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appropriate and adopted for a strategy to have short-term 
and sustained impact—community-based approaches 
reflect this principle. There is no ‘one size fits all’ solution 
that an alternative VCT will resolve. In the same light, 
there is no ‘magic bullet’, a combination of tools, used in 
judicious and appropriate manner, the IVM concept, has 
proven to impact disease transmission most effectively 
also with new VCTs coming to the market. The WIN net-
work has recently proposed a comprehensive framework 
for health authorities to devise and deliver sustainable, 
effective, integrated, community-based, locally adapted 
vector control strategies (IAM) in order to reduce the 
burden of Aedes-transmitted arboviruses [3].
Typically, an epidemic is over by the time vector con-
trol is initiated. The ability to prevent an ABV epidemic, 
and furthermore measures preventative impacts of an 
existing or alternative VCT requires precise and rigorous 
early-warning systems for both immatures and adults, 
implemented by vector control units. These units must 
have appropriate technical expertise and leadership. Par-
ticipants noted that technical capacity is missing and 
that many ABV endemic countries may not take these 
responsibilities. Leveraging the experience of the malaria 
control units to apply to arbovirus control was deemed 
a viable approach to consider overcoming this gap; how-
ever, it remains at a core that political will and financial 
support is ultimately needed. A proposed “Global Fund” 
for arboviral diseases should be a discussion point across 
stakeholders in order to facilitate building in-country 
capacity to respond more effectively to these threats.
Workshop participants raised considerations regarding 
how to evaluate the ‘success’ of new VCTs. Specifically, 
it was mentioned that identification of appropriate end-
points for a VCT is critical to measure its impact. It is 
important to ensure that the evidence is made available 
to stakeholders in order to facilitate decision-making on 
procurement and use. It was recognized that WHO is 
faced with governments asking for evidence. Without evi-
dence leaders cannot justify integrating a VCT into con-
trol programmes. For alternative VCTs where standard 
guidelines of efficacy testing are not available (e.g. SIT), 
such resources should be rapidly developed. Require-
ments are in place for large-scale epidemiological trials 
with randomized cluster trials (RCTs) to be considered 
the most informative studies [48]. RCTs are expensive 
to conduct but they are worth to generate the evidence 
needed to accelerate the deployment of new and effective 
VCTs. Where funding is limited, alternative study designs 
may be considered while accepting their limitations [48]. 
Modeling projections of impact was mentioned as a valu-
able component for study design development. Funding 
for epidemiological trials, regardless of design, must be 
forthcoming as without epidemiological evidence, WHO 
may not make recommendations for novel VCTs.
Although evidence is still lacking for most alternative 
strategies, they may offer great potential for mitigat-
ing insecticide resistance as part of an IVM approach 
through reduction of insecticide use, even if they are of 
a similar efficacy to existing interventions [6]. For exam-
ple, optimizing IRS to more efficiently target Ae. aegypti 
can reduce both application time and insecticide volume 
without reducing entomological efficacy. It was acknowl-
edged that public health is ‘starved’ for new active ingre-
dients whereas agriculture is not, and that this issue 
needs to be solved. For those alternative VCTs that are 
chemical-based continued interest and investment in 
R&D through PPPs such as IVCC should continue to be 
advocated for repurposing agricultural chemistries, with 
novel modes of action, for public health purposes. To 
further incentivize investment, industry partners in PPPs 
need IP protection for first-in-class products.
Finally, there is a need to continue exploring a diverse 
range of emerging products and technologies for ABV 
vector control, particularly for Aedes spp. (e.g. acoustic 
larvicide, electronic barriers, RNAI insecticides, “intel-
ligent traps”). The contribution of industry, foundations 
and international consortiums is essential for success. 
National legislation/regulatory framework will need to 
be adapted and/or be developed to address deployment 
of alternative VCTs with novel modes of action, without 
which evaluation and evidence-generation will be halted. 
These frameworks should be harmonized at the regional 
level to address cross-border concerns particularly where 
a new VCT such as the release of GM mosquitoes will 
have an impact beyond country borders. There is an 
urgent call for cross-sector coordination (i.e. multiple 
diseases, organizations, legislation) and continued finan-
cial support to achieve SDG 3.3.
Round Table 2: Insecticide resistance: a trick or a real threat 
for vector control? Where is the proof that it is having 
an operational impact?
Insecticide resistance is an increasing challenge for 
Aedes-borne disease prevention because most dengue, 
Zika and chikungunya control strategies rely heav-
ily on chemical control of the vector. Resistance or 
suspected resistance has been reported from at least 
57 countries, including those in Southeast Asia, the 
Americas and the Caribbean where the dengue burden 
is particularly high [4]. Following renewed enthusi-
asm for strengthening vector control capacity, as wit-
nessed at the May 2017 World Health Assembly [2], we 
need to assess whether those international efforts will 
be hindered by the presence and spread of resistance. 
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Despite increasing concern, the degree to which insec-
ticide resistance compromises Aedes control in the 
field remains largely unknown. Several entomological 
studies conducted in Latin America and the Caribbean 
show that insecticide resistance reduces the duration of 
efficacy for larval treatment [49, 50], the performances 
of pyrethroid space sprays and residual applications 
[51] and efficacy of household products [22, 52].
Further investigations are, however, needed to quan-
tify the links between molecular insecticide resistance 
mechanisms, allele frequencies, resistance phenotypes 
and operational impact. That information would facili-
tate a pre-emptive risk assessment of control failure 
and improve the capacity of public health authorities to 
deploy or register products with greatest field efficacy. 
This endeavor is challenged by the fact that we lack the 
molecular tools required to identify, monitor and inter-
pret anything other than a subset of resistance-associ-
ated mutations. As a consequence, we remain reliant on 
phenotypic studies; usually in the laboratory, but some-
times in the field, often augmented by the characteri-
zation of a small number of sodium channel mutations 
(known as kdr).
The purpose of Round Table  2 was to identify the 
impact of insecticide resistance on vector control 
operations and to identify related knowledge gaps. 
Participants in the discussion agreed that there are 
examples where the control of Ae. aegypti failed due 
to insecticide resistance (see references above), par-
ticularly for pyrethroids. Given that in most control 
programmes insecticide resistance is neither moni-
tored nor evaluated, it is assumed that resistance-
related control failures are under-reported and may be 
widespread. However, the group also recognizes that 
many control programmes do not have the resources 
to apply insecticides in an optimal manner leading to 
poor coverage, sub-standard operational practice (i.e. 
fogging outdoors in the heat of the day), and delayed 
responses [53]. There is no empirical evidence to link 
resistance-associated control failures to increased 
dengue, Zika or chikungunya transmission. However, 
until recently this has also been true for the more 
closely monitored and far better resourced malaria 
control programmes [54–57]. Studies specifically aim-
ing to detect the epidemiological impacts of resistance 
are exceptionally hard to design, control and imple-
ment [58–60], especially for arboviral, urban diseases 
that show spatially and temporally heterogeneous 
transmission [61].
Accurate, affordable predictors based on entomologi-
cal efficacy would be extremely useful for local authori-
ties implementing public health measures including 
the procurement of insecticides. Such predictors might 
include “intensity assays” that compared to a single 
diagnostic dose may offer better information on the 
magnitude of resistance [62]. In addition, molecular 
assays to identify common resistance mutations are 
now simple and affordable enough to warrant adoption 
by a range of local authorities.
Current molecular assays for routine surveillance 
describe only a subset of mechanisms but may, at least 
for pyrethroids, provide useful “proxies” for incipi-
ent phenotypic resistance [63, 64]. For other chemi-
cal classes, molecular or biochemical tools are not yet 
available that reliably predict the resistance phenotypes. 
Well-designed, properly controlled field-trials, with ento-
mological endpoints, especially those conducted against 
well-characterized phenotypes will help support the con-
clusions of more commonly applied bioassays and molec-
ular diagnostics.
The value in testing and monitoring phenotypes and 
genotypes lies mostly in confirming the continued util-
ity of existing chemistries. In the event that operation-
ally relevant levels of resistance are encountered, there 
are few options for a change in practice. One might argue 
that, given the ubiquity and continued spread of pyre-
throid resistance globally, all public health authorities 
should switch immediately to some kind of mosaic or 
rotation of pyrethroids, organophosphates, and carba-
mates to preserve mosquitoes susceptible. New chemi-
cal classes (e.g. butenolides, neonicotinoids) may help in 
this process as soon as they become available for large-
scale deployment. We suspect that, once a chemical class 
is lost, it will be lost forever as resistance to pyrethroids 
has been found to be irreversible [65], although that may 
be due to continued use of pyrethroids in commercially 
available household aerosols [22].
For other potential elements of IRM and IVM strat-
egies (e.g. untreated refuges, habitat management, 
biological control, late-life-acting insecticides) the evi-
dence-base is limited and does not have the same univer-
sal relevance to control programmes as do insecticides. 
Community engagement will remain crucial, even if it is 
merely to increase acceptance and coverage of insecticide 
programmes. Apart from cost and complexity, the rou-
tine rotation of different chemical classes is complicated 
by shared issues of insecticide tendering and stockpiling.
Summary and role for WIN
• Chemical insecticides remain the cornerstone of 
arbovirus vector control. In the medium term, there 
are no globally applicable alternatives. As a conse-
quence, preserving the susceptibility to conventional 
insecticides should be the priority to all stakeholders 
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and policy makers involved in vector borne disease 
control [66].
• When applied at high coverage, chemical-based 
interventions do have entomological impact, 
although epidemiological assessments of efficacy 
are rare [3]. Consequently, prioritisation of vec-
tor control strategies is difficult. The development 
of a “Global Fund” for ABVs would help to build in-
country capacity to implement, monitor and evalu-
ate interventions in order to generate the evidence 
require for decision making.
• Currently, it is hard to discriminate between vec-
tor control failures caused by sub-optimal use or by 
insecticide resistance. Regionally relevant trials, con-
ducted against well-characterized IR mosquito popu-
lations, should be conducted to make an informed 
choice of intervention.
• Insecticide resistance is not binary, but rather contin-
uous trait and lower levels of resistance may, tempo-
rarily, overcome by increased application rates. Accu-
rate assessment of the phenotype and early detection 
of mutations that confer resistance can help to adjust 
vector control policies before operational conse-
quences or intervention failures occur.
• Few operational teams or national authorities have 
the capacities to monitor insecticide resistance in 
routine. However, research institutions can provide 
support to local authorities by training public health 
officers, share laboratories, provide the expertise to 
design trials, and evaluate vector control interven-
tions [3].
• All public health authorities tend to use single prod-
ucts until they fail. Unfortunately, the pipeline of 
new public health insecticides is very narrow, which 
means that older products cannot be removed and 
replaced with new ones when resistance is detected 
in a target mosquito population. WIN advocates for 
promoting routine substitutions/rotations between 
chemical classes that proved to be effective against 
the target species and/or deployment of non-chem-
ical strategies [6], even at higher immediate cost in 
order to preserve susceptibility over the long term.
• WIN can help defining operational best practice, 
norms and guidance for IRM and develop Standard 
Operating Practices for monitoring and evaluation of 
IRM strategies.
• WIN can advocate for funding for training courses 
and regionally relevant trials as well as for the devel-
opment of regulatory framework to promote the con-
cept of susceptibility in vector control programmes.
Conclusions
Aedes-borne viral diseases are rapidly spreading globally, 
causing increasing health and economic losses. Social, 
environmental, and demographic changes have facili-
tated the selection, spread and proliferation of viruses, 
vectors and resistant alleles into new areas [67] and has 
probably driven an increased use of insecticides by both 
households and public health authorities. As a conse-
quence, the number of countries that have reported 
insecticide resistance in Aedes mosquitoes have dramati-
cally increased in the last decade [4]. A striking example 
is the recent introduction of the V1016G kdr mutation 
conferring resistance to pyrethroids in Ae. albopictus 
in Europe for the first time in history [19]. Resistance 
is now recognized as a growing public health challenge 
threatening the global fight against vector borne diseases. 
Despite the development of a dengue vaccine, its limited 
efficacy and the lack of any vaccines or drugs for other 
ABVs such as Zika and chikungyunya means that insecti-
cides will remain an essential part of Aedes-borne disease 
control programmes and outbreak responses. It is critical 
to preserve as long as we can the “lifespan” of new and 
existing molecules. As such, incentives and regulatory 
frameworks to support the concept of insecticide suscep-
tibility of vectors as a “public good” should be considered 
[66]. Since 2016, the WIN has established a network of 
internationally recognized experts to improve the sur-
veillance and control of insecticide resistance in vectors 
of emerging arboviruses. The missions are to raise aware-
ness and mobilize resources for strengthening country 
capacity in resistance monitoring, stimulating research 
efforts, advise decision makers for resistance manage-
ment, and strengthen public-private partnership to accel-
erate the deployment of integrated VCTs. The ultimate 
goal of WIN is to support international efforts to reduce 
the global burden of ABVs by 2030.
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